- Erratum: Figure Correction: Probiotics as Complementary Treatment for Metabolic Disorders
-
Le Barz M, Anhe FF, Varin TV, Desjardins Y, Levy E, Roy D, Urdaci MC, Marette A
- KMID: 2174021
- Diabetes Metab J.
- 2015 Oct;39(5):448-449.
- doi: 10.4093/dmj.2015.39.5.448
There was a spelling error in the Fig 2. -
- CITED
-
- Close
- SHARE
-
- Close
- Probiotics as Complementary Treatment for Metabolic Disorders
-
Le Barz M, Anhe FF, Varin TV, Desjardins Y, Levy E, Roy D, Urdaci MC, Marette A
- KMID: 2174024
- Diabetes Metab J.
- 2015 Aug;39(4):291-303.
- doi: 10.4093/dmj.2015.39.4.291
Over the past decade, growing evidence has established the gut microbiota as one of the most important determinants of metabolic disorders such as obesity and type 2 diabetes. Indeed, obesogenic... -
- CITED
-
- Close
- SHARE
-
- Close
- Analyzing the Association of Visceral Adipose Tissue Growth Differentiation Factor-15 and MicroRNA in Type 2 Diabetes Mellitus
-
Roy D, Purohit P, Khokhar M, Modi A, Shukla RKG, Chaudhary R, Sankanagoudar S, Sharma P
- KMID: 2541137
- J Obes Metab Syndr.
- 2023 Mar;32(1):64-76.
- doi: 10.7570/jomes22010
Background: Growth differentiation factor-15 (GDF-15) is involved in insulin resistance and diabetes. In this study, we determine the associations of GDF-15 with miR-181b-5p, miR-330-3p, mothers against decapentaplegic homolog 7 (SMAD7),... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunohistochemical Analysis of the Expression of Cytokeratins in Acquired Cholesteatoma and Its Clinico-Radiological Correlation
-
Kanodia A, Kakkar A, Verma Y, Roy D, Verma H, Singh CA, Monga R, Jain D, Thakar A, Sikka K
- KMID: 2541542
- J Audiol Otol.
- 2023 Apr;27(2):97-103.
- doi: 10.7874/jao.2022.00451
Background and Objectives: Cholesteatomatous chronic otitis media acquires epithelial proliferation and differentiation characteristics, which render it able to erode the underlying bone and cause complications. We attempt to characterize the... -
- CITED
-
- Close
- SHARE
-
- Close
- Endovascular Therapy in the Extended Time Window for Large Vessel Occlusion in Patients With Pre-Stroke Disability
-
Tanaka K, Yamagami H, Qureshi MM, Uchida K, Siegler JE, Nogueira RG, Yoshimura S, Sakai N, Martinez-Majander N, Nagel S, Demeestere J, Puetz V, Haussen DC, Abdalkader M, Olive-Gadea M, Mohammaden MH, Marto JP, Dusart A, Winzer S, Tomppo L, Caparros F, Henon H, Bellante F, Ramos JN, Ortega-Gutierrez S, Sheth SA, Nannoni S, Kaesmacher J, Vandewalle L, Salazar-Marioni S, Farooqui M, Virtanen P, Ventura R, Zaidi S, Castonguay AC, Puri AS, Farzin B, Masoud HE, Klein P, Jesser J, Requena M, Dobrocky T, Kaiser DP, Peltola E, Strambo D, Möhlenbruch MA, Lin E, Ringleb PA, Zaidat OO, Cordonnier C, Roy D, Lemmens R, Ribo M, Strbian D, Fischer U, Michel P, Raymond J, Nguyen TN
- KMID: 2556047
- J Stroke.
- 2024 May;26(2):269-279.
- doi: 10.5853/jos.2023.04259
Background and Purpose We compared the outcomes of endovascular therapy (EVT) in an extended time window in patients with large-vessel occlusion (LVO) between patients with and without pre-stroke disability. Methods In... -
- CITED
-
- Close
- SHARE
-
- Close
